PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31276961-4	2019	This effect is selective as mefloquine is more effective in inducing apoptosis, inhibiting colony formation and self-renewal capacity of CD34+ cells derived from TKI-resistant BP-CML patients than normal cord blood (CB) CD34+ stem/progenitor cells.	Mefloquine	28-38	CD34 molecule	Homo sapiens	137-141	
31276961-4	2019	This effect is selective as mefloquine is more effective in inducing apoptosis, inhibiting colony formation and self-renewal capacity of CD34+ cells derived from TKI-resistant BP-CML patients than normal cord blood (CB) CD34+ stem/progenitor cells.	Mefloquine	28-38	CD34 molecule	Homo sapiens	220-224	
31276961-5	2019	Notably, the combination of mefloquine and TKIs at sublethal concentrations leads to synergistic effects in CML CD34+ cells, while sparing normal CB CD34+ cells.	Mefloquine	28-38	CD34 molecule	Homo sapiens	112-116	
31276961-5	2019	Notably, the combination of mefloquine and TKIs at sublethal concentrations leads to synergistic effects in CML CD34+ cells, while sparing normal CB CD34+ cells.	Mefloquine	28-38	CD34 molecule	Homo sapiens	149-153